Showing 1 - 10 of 6,271
The for-profit hospital is in the minority numerically in all developed countries. Although the for-profits' market share has been quite stable for decades, for-profit chains have grown in share and influence in the United States. By contrast, for-profit chains have made few inroads in other...
Persistent link: https://www.econbiz.de/10014024184
This work shows some aspects of the relation between for-profits and nonprofits hospitals in the realm of the Brazilian National Health System (SUS). We emphasize the for-profit and not-for-profit orientations of the hospitals rather than focusing on the usual private versus public dichotomy. By...
Persistent link: https://www.econbiz.de/10014069367
This chapter examines the role of altruistic motives in the economic analysis of public social transfers, both from a positive and from a normative point of view. The positive question is to know whether we can fully neglect altruistic considerations to explain the development or sustainability...
Persistent link: https://www.econbiz.de/10014023654
Neue empirische Evidenz für Leistungsanbieter im Gesundheitswesen zeigt, dass es erhebliche Heterogenität im Grad des …
Persistent link: https://www.econbiz.de/10010417198
We build up a differential game to investigate the interplay between the quality of health care and the presence of an evolving disease in a duopoly where patients are heterogeneous along the income dimension. We prove unicity, stability and perfection of the open-loop Nash solution. Moreover,...
Persistent link: https://www.econbiz.de/10011737232
We build up a differential game to investigate the interplay between the quality of health care and the presence of an evolving disease in a duopoly where patients are heterogeneous along the income dimension. We prove unicity, stability and perfection of the open-loop Nash solution. Moreover,...
Persistent link: https://www.econbiz.de/10014185008
These are neither the best of times nor the worst of times for the pharmaceutical industry, or for global public health. Media reports regarding recent legal developments would suggest that the originator pharmaceutical industry is facing a new and dangerous threat to its long-term welfare,...
Persistent link: https://www.econbiz.de/10014141859
Persistent link: https://www.econbiz.de/10000882384
Persistent link: https://www.econbiz.de/10000888480
Persistent link: https://www.econbiz.de/10000893433